Updated hourlyHourly refreshWed, Jul 22, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
Lila Karoub has completed a new book, "I Was A Therapist": True Case Studies of Child Abuse, Attempted Murder, and Marital Torture, a candid examination of the most challenging and transformative moments from her decades as a practicing psychotherapist. Drawing from her clinical experience, Karoub recounts pivotal cases involving attempted homicide, severe childhood trauma, and intimate partner [PR.com]
Jul 15 · 10:00·PR.com
Healthcare
Doha, Qatar – , 2026-07-15 — /EPR Network/ — First Vet is happy to offer trusted Veterinary Lab Testing in Doha for pets. The clinic [read full press release...]
Jul 15 · 09:43·Express Press Release
Finance · Healthcare
Tokyo, Japan and Cambridge and London, UK, 15 July 2026 – Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings results and present operational highlights for 2Q 2026 on Friday, 7 August 2026. The Company will host a live webinar presentation with Chris Cargill (President, CEO), Hironoshin Nomura (CFO), Toshi Maeda (COO) and Patrik Foerch (CSO and President of Nxera Pharma UK), at 5:00 pm JST (9:00 am GMT) on Friday, 7 August 2026. The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar. Presentation slides will be made available by 4:30 pm JST (8:30 am GMT) on 7 August 2026 through the inve
Jul 15 · 09:13·GlobeNewswire
SaaS · Healthcare
Across three independent studies, the NeuLogiq® Platform two-minute tablet-based Symbol Swap task delivered clinically meaningful discrimination between control, MCI and Alzheimer's dementia groups and detected blood-biomarker-defined pathology — including in clinically normal individuals...
Jul 15 · 09:11·PR Newswire
Healthcare · Retail
Research Highlights: In an analysis of the Global Burden of Disease Study compared with U.S. Census data from 1990-2021, researchers found that people with congenital heart disease living in states with lower average household incomes and fewer people with health insurance had higher rates of death and disability. The research authors hypothesize that this difference may be due to easier access to specialized care and treatment from adult congenital heart disease cardiologists in communities with higher income levels and more residents with health insurance. Congenital heart disease requires lifelong, regular access to specialized cardiac care. Expanding access to expert care, particularly in under-resourced regions of the U.S., could play a profound role in improving survival and quality
Jul 15 · 09:00·NewMediaWire
Healthcare
Norwalk, USA, 2026-07-15 — /EPR Network/ — Beautiful skin is more than a trend. It is a reflection of healthy care and self-confidence. Lzur Day [read full press release...]
Jul 15 · 07:34·Express Press Release
Healthcare
Dr. David B. Hardin of Noblesville, Indiana has been named Professional of the Year for Healthcare, Rehabilitation, and Wound Care by Strathmore's Who's Who Worldwide for his outstanding contributions and achievements in his field. About Dr. David B. Hardin Dr. David B. Hardin is a physician serving patients through his medical practice in Indiana, offering patient care and related services. With more than four decades [PR.com]
Jul 15 · 07:00·PR.com
Healthcare
Research collaboration highlights safe surgical outcomes and significant health improvements in young patients in Louisiana [PR.com]
Jul 15 · 07:00·PR.com
Healthcare · Education
Continuous smartwatch monitoring shown to safely support post-surgical care, reducing disruptions for patients and easing nursing time for direct patient care SINGAPORE, July 14, 2026 /PRNewswire/ -- The National University Hospital (NUH) is set to expand the use of wearable technology...
Jul 15 · 06:58·PR Newswire
Healthcare
Der Bericht hebt saubere Energie, Innovation und ESG-Anerkennung hervor ZIBO, China, 15. Juli 2026 /PRNewswire/ -- INTCO Medical („das Unternehmen"), ein weltweit führender Hersteller von Einweghandschuhen, hat seinen ESG-Bericht (Umwelt, Soziales und Unternehmensführung) für 2025...
Jul 15 · 05:46·PR Newswire
Healthcare
Basel, 15 July 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has granted Priority Review to the company’s supplemental Biologics License Application (sBLA) for Gazyva®/Gazyvaro® (obinutuzumab) for the treatment of primary membranous nephropathy (pMN). The priority review is based on the positive phase III MAJESTY results, which show superiority of Gazyva/Gazyvaro over an immunosuppressive therapy, tacrolimus, in adults with pMN. 1 The FDA has already granted Breakthrough Therapy Designation (BTD) to Gazyva/Gazyvaro in pMN and is expected to make a decision on approval by November 2026. This is the second indication in recent months for which the US FDA has granted priority review to Gazyva/Gazyvaro, following idiopathic nephrotic s
Jul 15 · 05:00·GlobeNewswire
Finance · Healthcare
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today highlights its approaches to overcoming target limitations in radioligand therapy (RLT) through Radio-DARPins, in a presentation at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer in Newry, Maine, US.
Jul 15 · 05:00·GlobeNewswire